180 related articles for article (PubMed ID: 34015971)
1. DMSA-coated cubic iron oxide nanoparticles as potential therapeutic agents.
Çitoğlu S; Coşkun ÖD; Tung LD; Onur MA; Thanh NTK
Nanomedicine (Lond); 2021 May; 16(11):925-941. PubMed ID: 34015971
[No Abstract] [Full Text] [Related]
2. Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis.
Zhang X; Kong F; Wang T; Huang X; Li W; Zhang M; Wen T; Liu J; Zhang Y; Meng J; Xu H
Nanotoxicology; 2022; 16(9-10):829-843. PubMed ID: 36660964
[TBL] [Abstract][Full Text] [Related]
3. Effects of phase transfer ligands on monodisperse iron oxide magnetic nanoparticles.
Palma SICJ; Marciello M; Carvalho A; Veintemillas-Verdaguer S; Morales MDP; Roque ACA
J Colloid Interface Sci; 2015 Jan; 437():147-155. PubMed ID: 25313478
[TBL] [Abstract][Full Text] [Related]
4. Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
Silva LH; da Silva JR; Ferreira GA; Silva RC; Lima EC; Azevedo RB; Oliveira DM
J Nanobiotechnology; 2016 Jul; 14(1):59. PubMed ID: 27431051
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the influence of synthetic paramaters on the structure and physico-chemical properties of non-spherical iron oxide nanocrystals and their biological stability and compatibility.
Pardo A; Pujales R; Blanco M; Villar-Alvarez EM; Barbosa S; Taboada P; Mosquera V
Dalton Trans; 2016 Jan; 45(2):797-810. PubMed ID: 26647232
[TBL] [Abstract][Full Text] [Related]
6. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization of 2-deoxy-D-glucose functionalized dimercaptosuccinic acid-coated maghemite nanoparticles for targeting tumor cells.
Xiong F; Zhu ZY; Xiong C; Hua XQ; Shan XH; Zhang Y; Gu N
Pharm Res; 2012 Apr; 29(4):1087-97. PubMed ID: 22173782
[TBL] [Abstract][Full Text] [Related]
8. DMSA-Coated Iron Oxide Nanoparticles Greatly Affect the Expression of Genes Coding Cysteine-Rich Proteins by Their DMSA Coating.
Zhang L; Wang X; Zou J; Liu Y; Wang J
Chem Res Toxicol; 2015 Oct; 28(10):1961-74. PubMed ID: 26378955
[TBL] [Abstract][Full Text] [Related]
9. A value-added exopolysaccharide as a coating agent for MRI nanoprobes.
Palma SI; Rodrigues CA; Carvalho A; Morales Mdel P; Freitas F; Fernandes AR; Cabral JM; Roque AC
Nanoscale; 2015 Sep; 7(34):14272-83. PubMed ID: 26186402
[TBL] [Abstract][Full Text] [Related]
10. Quantification and biodegradability assessment of meso-2,3-dimercaptosuccinic acid adsorbed on iron oxide nanoparticles.
Bemowsky S; Rother A; Willmann W; Köser J; Markiewicz M; Dringen R; Stolte S
Nanoscale Adv; 2019 Sep; 1(9):3670-3679. PubMed ID: 36133553
[TBL] [Abstract][Full Text] [Related]
11. Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles.
Mejías R; Pérez-Yagüe S; Roca AG; Pérez N; Villanueva A; Cañete M; Mañes S; Ruiz-Cabello J; Benito M; Labarta A; Batlle X; Veintemillas-Verdaguer S; Morales MP; Barber DF; Serna CJ
Nanomedicine (Lond); 2010 Apr; 5(3):397-408. PubMed ID: 20394533
[TBL] [Abstract][Full Text] [Related]
12. Detection of human breast cancer cells using a 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles.
Shan XH; Wang P; Xiong F; Lu HY; Hu H
Cancer Biomark; 2017; 18(4):367-374. PubMed ID: 28106540
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
[TBL] [Abstract][Full Text] [Related]
14. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications.
Mejías R; Gutiérrez L; Salas G; Pérez-Yagüe S; Zotes TM; Lázaro FJ; Morales MP; Barber DF
J Control Release; 2013 Oct; 171(2):225-33. PubMed ID: 23906866
[TBL] [Abstract][Full Text] [Related]
15. MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles.
Shan XH; Wang P; Xiong F; Gu N; Hu H; Qian W; Lu HY; Fan Y
Mol Imaging Biol; 2016 Feb; 18(1):24-33. PubMed ID: 26150194
[TBL] [Abstract][Full Text] [Related]
16. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
Calero M; Chiappi M; Lazaro-Carrillo A; Rodríguez MJ; Chichón FJ; Crosbie-Staunton K; Prina-Mello A; Volkov Y; Villanueva A; Carrascosa JL
J Nanobiotechnology; 2015 Feb; 13():16. PubMed ID: 25880445
[TBL] [Abstract][Full Text] [Related]
17. DMSA-coated IONPs trigger oxidative stress, mitochondrial metabolic reprograming and changes in mitochondrial disposition, hindering cell cycle progression of cancer cells.
Daviu N; Portilla Y; Gómez de Cedrón M; Ramírez de Molina A; Barber DF
Biomaterials; 2024 Jan; 304():122409. PubMed ID: 38052135
[TBL] [Abstract][Full Text] [Related]
18. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes.
Geppert M; Hohnholt MC; Thiel K; Nürnberger S; Grunwald I; Rezwan K; Dringen R
Nanotechnology; 2011 Apr; 22(14):145101. PubMed ID: 21346306
[TBL] [Abstract][Full Text] [Related]
19. Potential Use of DMSA-Containing Iron Oxide Nanoparticles as Magnetic Vehicles against the COVID-19 Disease.
Martins ES; Espindola A; Britos TN; Chagas C; Barbosa E; Castro CE; Fonseca FLA; Haddad PS
ChemistrySelect; 2021 Aug; 6(31):7931-7935. PubMed ID: 34541297
[TBL] [Abstract][Full Text] [Related]
20. Step-by-Step Protocol for Superparamagnetic Nanoparticle-Based Endosome and Lysosome Isolation from Eukaryotic Cell.
Thimiri Govinda Raj DB; Khan NA; Venkatachalam S; Chu DT; Arumugam S
Methods Mol Biol; 2020; 2125():167-172. PubMed ID: 30771190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
